Renaxen 1 — Axitinib 1 mg, 120 product-page.units_short, Everest
100% original product

Renaxen 1 Tablets — Axitinib 1 mg (120 Tabs) Everest

30722₴ 37305₴ -18%

Renaxen 1 mg (Axitinib) is a potent and selective tyrosine kinase inhibitor targeting vascular endothelial growth factor receptors (VEGFR-1, -2, and -3). It acts as a generic equivalent to Inlyta. By inhibiting these receptors, Axitinib blocks angiogenesis (the formation of new blood vessels), effectively starving the tumor of nutrients and oxygen.

Manufacturer: Everest Pharmaceuticals (Bangladesh). The 1 mg strength is specifically useful for dose titration and management of adverse reactions.

Key Features:

  • Anti-Angiogenic: Directly halts the blood supply to the tumor.
  • Advanced RCC Therapy: Proven efficacy in treating kidney cancer after failure of prior systemic treatments.
  • Dosage Flexibility: Low-dose 1 mg tablets allow for precise dose reduction or adjustment as mandated by the patient's tolerance.

Prescribed by oncologists for the treatment of adult patients with:

  • 🔹 Advanced Renal Cell Carcinoma (RCC): Specifically indicated after failure of one prior systemic therapy (e.g., sunitinib or cytokine-based regimens).

Sales Unit: Box containing 120 tablets (1 mg strength).

⚠️ APPLICATION INSTRUCTIONS:

  • Standard Starting Dose: Typically 5 mg taken orally twice daily. Note: Since these are 1 mg tablets, multiple tablets may be required to reach the prescribed dose. Always follow your oncologist's count.
  • Use of 1 mg: Often prescribed when a patient needs to reduce the dose (e.g., to 3 mg or 2 mg BID) due to side effects.
  • Administration: Take doses approximately 12 hours apart. Can be taken with or without food. Swallow whole with a full glass of water.
  • Missed Dose: If a dose is missed or vomiting occurs, do not take an extra dose. Resume the regular schedule at the next time.
  • Pregnancy & Breastfeeding: Strictly contraindicated. Can cause fetal harm.
  • Hypersensitivity to Axitinib.
  • Severe hepatic impairment (Child-Pugh Class C).
  • History of arterial thromboembolic events (stroke, heart attack) within the last 12 months.
  • Uncontrolled hypertension.

Blood pressure and thyroid function must be monitored regularly. Potential side effects include:

  • 📈 Hypertension: High blood pressure (very common).
  • 🤢 Gastrointestinal: Diarrhea, nausea, vomiting, decreased appetite.
  • 🗣️ Dysphonia: Hoarseness or voice changes.
  • 🦋 Thyroid: Hypothyroidism (low thyroid hormone levels).
  • Skin: Hand-Foot Syndrome (Palmar-plantar erythrodysesthesia).
Active ingredient
Manufacturer
Everest
Dosage 1 mg
Dosage form Tablets
Tablets per pack 120
100% original product
Delivery across Ukraine
Alternatives

Similar products

Inlybest 5 mg Aprazer
View
Aprazer

Inlybest

5 mg 28 tablets
5267₴ 5705₴
Renaxen 5 5 mg Everest
View
Everest

Renaxen 5

5 mg 60 tablets
26333₴ 30722₴
Customer reviews

What Customers Say

No reviews yet

Your review can be the first!

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00